2nd Quarter - Report

AMERICA'S BLOOD CENTERS for AMERICA'S BLOOD CENTERS

Firm
Client
Income
—
Expenses
$20,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Disaster Planning/Emergencies DIS

Blood centers disaster preparedness and response activities, impact of COVID-19 on the blood supply

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE

Health Issues HCR

Blood and blood product reimbursement, recruitment of blood donors, blood donation awareness, impact of COVID-19 on blood supply, infectious disease testing, FDA guidance on individual risk assessments for donor deferral, access to blood in hospice and pre-hospital settings

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: Centers For Disease Control & Prevention (CDC); Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); White House Office; SENATE; Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Medical/Disease Research/Clinical Labs MED

Value of Blood/Reimbursement, laboratory developed tests

LobbyistCovered position, as disclosed
DIANE RETA CALMUS —
KATE FRY —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE; Food & Drug Administration (FDA)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.